TP53 and cervical carcinoma: In the present study, we observed that FTS silencing reduced the expression of E6 and E7 oncoproteins; consequently, the expression levels of p53, pRb, and their phosphorylated forms, were elevated in both cervical cancer cell lines (Fig 1B and 1C).